Clinical Trial Update: Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Mycobacterium w in patients with BCG-refractory superficial transitional cell carcinoma of the bladder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Bladder

Drugs mentioned

• Mycobacterium w (Mycobacterium w)

Snippet

Sponsor: Cadila Pharnmaceuticals | Conditions: Bladder Cancer | Phase 1 | Status: COMPLETED